582 related articles for article (PubMed ID: 9888428)
1. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Yoles E; Wheeler LA; Schwartz M
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
[TBL] [Abstract][Full Text] [Related]
2. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
[TBL] [Abstract][Full Text] [Related]
3. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Am J Ophthalmol; 2009 Feb; 147(2):326-31. PubMed ID: 18835468
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
5. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.
Lönngren U; Näpänkangas U; Lafuente M; Mayor S; Lindqvist N; Vidal-Sanz M; Hallböök F
Brain Res Bull; 2006 Dec; 71(1-3):208-18. PubMed ID: 17113948
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T
J Glaucoma; 2009 Jan; 18(1):26-31. PubMed ID: 19142131
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
Baptiste DC; Hartwick AT; Jollimore CA; Baldridge WH; Chauhan BC; Tremblay F; Kelly ME
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2666-76. PubMed ID: 12147601
[TBL] [Abstract][Full Text] [Related]
9. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats.
Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK
Exp Eye Res; 2011 Feb; 92(2):112-9. PubMed ID: 21185832
[TBL] [Abstract][Full Text] [Related]
10. The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model.
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Acta Ophthalmol; 2010 Aug; 88(5):553-7. PubMed ID: 19681765
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats.
Tsai RK; Chang CH; Wang HZ
Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of alpha(2)-selective adrenergic agonists against ischemia-induced retinal ganglion cell death.
Lafuente MP; Villegas-Pérez MP; Sobrado-Calvo P; García-Avilés A; Miralles de Imperial J; Vidal-Sanz M
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2074-84. PubMed ID: 11481275
[TBL] [Abstract][Full Text] [Related]
14. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury.
Wheeler LA; Lai R; Woldemussie E
Eur J Ophthalmol; 1999; 9 Suppl 1():S17-21. PubMed ID: 10230601
[TBL] [Abstract][Full Text] [Related]
15. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies.
Yoles E; Schwartz M
Exp Neurol; 1998 Sep; 153(1):1-7. PubMed ID: 9743562
[TBL] [Abstract][Full Text] [Related]
16. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model.
Thaler S; Fiedorowicz M; Grieb P; Wypych Z; Knap N; Borowik T; Zawada K; Kaminski J; Wozniak M; Rejdak R; Zrenner E; Schuettauf F
Acta Ophthalmol; 2011 Nov; 89(7):e555-60. PubMed ID: 21645284
[TBL] [Abstract][Full Text] [Related]
18. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
Wheeler LA; Woldemussie E
Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
[TBL] [Abstract][Full Text] [Related]
19. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
Ben Simon GJ; Bakalash S; Aloni E; Rosner M
Am J Ophthalmol; 2006 Jun; 141(6):1105-11. PubMed ID: 16765680
[TBL] [Abstract][Full Text] [Related]
20. A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.
Karim Z; Sawada A; Kawakami H; Yamamoto T; Taniguchi T
Curr Eye Res; 2006 Mar; 31(3):273-83. PubMed ID: 16531285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
